Investigating the Safety of Fampridine in Patients with Different Stages of Multiple Sclerosis

Investigating the Safety of Fampridine in Patients with Different Stages of Multiple Sclerosis

Background: Fampridine is the only drug approved by the US Food and Drug Administration (FDA) for people with multiple sclerosis (MS) to improve their movement and has exhibited a clinically significant improvement in gait function in a subset of MS patients with Expanded Disability Status Scale (ES...

Full description

Saved in:
Bibliographic Details
Main Authors: Saeed Vaheb, Mahour Farzan, Alireza Afshari-Safavi, Narges Ebrahimi, Vahid Shaygannejad, Omid Mirmosayyeb
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2025-01-01
Series:International Journal of Preventive Medicine
Subjects:
drug adverse reactions
fampridine
multiple sclerosis
safety
Online Access:https://journals.lww.com/10.4103/ijpvm.ijpvm_292_23
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items